Evolent Health Inc [NYSE: EVH] surged by $5.53 during the normal trading session on while it closed the day at $26.40.
Evolent Health Inc stock has also gained 16.92% of its value over the past 7 days. However, EVH stock has declined by -2.08% in the 3 months of the year. Over the past six months meanwhile, it has lost -13.81% and lost -20.07% year-on date.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The market cap for EVH stock reached $3.07 billion, with 113.89 million shares outstanding and 110.59 million shares in the current float. Compared to the average trading volume of 2.05M shares, EVH reached a trading volume of 9228266 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here’s what leading stock market gurus have to say about Evolent Health Inc [EVH]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for EVH shares is $39.86 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on EVH stock is a recommendation set at 1.20. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Truist have made an estimate for Evolent Health Inc shares, keeping their opinion on the stock as Buy, with their previous recommendation back on August 09, 2024. While these analysts kept the previous recommendation, Citigroup raised their target price to Buy. The new note on the price target was released on April 22, 2024, representing the official price target for Evolent Health Inc stock. Previously, the target price had yet another raise to $45, while Oppenheimer analysts kept a Outperform rating on EVH stock.
The Average True Range (ATR) for Evolent Health Inc is set at 1.73, with the Price to Sales ratio for EVH stock in the period of the last 12 months amounting to 1.30. The Price to Book ratio for the last quarter was 2.87, with the Price to Cash per share for the same quarter was set at 1.04. Price to Free Cash Flow for EVH in the course of the last twelve months was 20.33 with Quick ratio for the last quarter at 1.08.
EVH stock trade performance evaluation
Evolent Health Inc [EVH] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 16.92. With this latest performance, EVH shares gained by 34.56% in over the last four-week period, additionally sinking by -13.81% over the last 6 months – not to mention a drop of -6.38% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for EVH stock in for the last two-week period is set at 66.77, with the RSI for the last a single of trading hit 71.18, and the three-weeks RSI is set at 62.94 for Evolent Health Inc [EVH]. The present Moving Average for the last 50 days of trading for this stock 21.41, while it was recorded at 22.10 for the last single week of trading, and 27.56 for the last 200 days.
Evolent Health Inc [EVH]: An insightful look at the core fundamentals
Evolent Health Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 1.08 and a Current Ratio set at 1.08.
Earnings per share (EPS) analysis for Evolent Health Inc [EVH] stock
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for EVH. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Evolent Health Inc go to 30.00%.
Evolent Health Inc [EVH]: Institutional Ownership
The top three institutional holders of EVH stocks are: VANGUARD GROUP INC with ownership of 1.32 billion shares, which is approximately 8.5034%. BLACKROCK INC., holding 1.04 billion shares of the stock with an approximate value of $178.43 billion in EVH stocks shares; and BERKSHIRE HATHAWAY INC, currently with $135.36 billion in EVH stock with ownership which is approximately 5.1238%.
